Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -224,717 | -157,848 | -88,015 | -314,248 | -229,864 |
| Depreciation Amortization | 4,747 | 3,267 | 2,361 | 17,074 | 13,843 |
| Income taxes - deferred | -10,706 | N/A | N/A | N/A | N/A |
| Accounts receivable | -11,700 | -5,248 | -10,803 | 5,455 | 1,485 |
| Accounts payable and accrued liabilities | 1,706 | 4,262 | 5,068 | 1,025 | 1,511 |
| Other Working Capital | -51,217 | -38,622 | -43,129 | -53,972 | -48,290 |
| Other Operating Activity | 90,274 | 57,757 | 39,827 | 81,455 | 58,670 |
| Operating Cash Flow | $-201,613 | $-136,432 | $-94,691 | $-263,211 | $-202,645 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 78,100 | -165,155 | -68,832 | 133,012 | 47,526 |
| PPE Investments | -6,819 | -5,989 | -3,721 | -16,750 | -11,846 |
| Net Acquisitions | -102 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -179 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -179 | 0 |
| Investing Cash Flow | $71,179 | $-171,144 | $-72,553 | $116,083 | $35,680 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,397 | -911 | -446 | -1,608 | -1,180 |
| Common Stock Issued | 203,583 | 199,021 | 196,435 | 11,230 | 9,983 |
| Other Financing Activity | -11,693 | -6,836 | 0 | 0 | 0 |
| Financing Cash Flow | $190,493 | $191,274 | $195,989 | $9,622 | $8,803 |
| Beginning Cash Position | 328,311 | 328,311 | 328,311 | 465,817 | 465,817 |
| End Cash Position | 388,370 | 212,009 | 357,056 | 328,311 | 307,655 |
| Net Cash Flow | $60,059 | $-116,302 | $28,745 | $-137,506 | $-158,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -201,613 | -136,432 | -94,691 | -263,211 | -202,645 |
| Capital Expenditure | -6,819 | -5,989 | -3,721 | -16,750 | -11,846 |
| Free Cash Flow | -208,432 | -142,421 | -98,412 | -279,961 | -214,491 |